FundingHealthcare & Life Sciences
4baseCare raises Rs 128 Cr in Series B round
By Abha Lohia · Editor ·
4baseCare: revenue and funding and every story →
Series BFounded 2019
- 4baseCare provides AI-led genomic cancer diagnostics through its OncoTwin platform
- The company closed a Series B round of Rs 128 Cr with growX Ventures leading the top-up
- Funds support global expansion and lower pricing for underrepresented populations
What happened
- 4baseCare has closed its Series B funding round totaling Rs 128 Cr.
- The total amount includes an earlier tranche of Rs 90 Cr and a top-up of Rs 38 Cr.
- growX Ventures led the top-up investment round with participation from existing backers.
- Infosys participated as a strategic innovation investor in this latest funding stage.
- Co-lead investors for the initial Series B tranche were Ashish Kacholia and Lashit Sanghvi.
- Existing backer Yali Capital also participated in the current funding round.
- The company reported annual revenue of approximately Rs 40 Cr at the time of closing.
- 4baseCare aims to cross Rs 100 Cr in revenue within the next 12-18 months.
Why it matters
- India sees around 15 lakh new cancer cases annually according to market context.
- Approximately 70% of these cases are diagnosed at advanced stages in India.
- The startup addresses the underrepresentation of non-Caucasian populations in genomic data globally.
- Adoption is spreading from tier 1 cities to tier 2 and tier 3 locations.
The business
- 4baseCare focuses on precision oncology and genomics-driven cancer diagnostics services.
- Its core product is the OncoTwin platform which uses AI clinical decision support.
- The platform analyzes multimodal datasets including genomic, pathology, radiology, and clinical data.
- The company operates 4 active labs currently within India.
- It performs approximately 1,500 genomic tests per month at present capacity.
- Projected monthly test volume is expected to reach 8,000-10,000 tests soon.
- The firm pursues a strategy of lower prices compared to competitors.
- Some offerings cost nearly one-fourth of what competitor services charge.
The founders
HG
Hitesh Goswami
Co-founder and CEOKR
Kshitij Rishi
Co-founderWho put in money
- growX Ventures lead
- Infosys participant — Strategic innovation investment arm
- Yali Capital existing — Led previous Series A round
In numbers
Rs 128 CrTotal Funding Raised · 2026
Rs 40 CrAnnual Revenue · 2026
1,500Monthly Tests · 2026
4Active Labs · 2026
What happens next
- Plans to expand lab network to Middle East, Southeast Asia, Latin America, and Central Asia.
- Targeting entry into 8-10 additional countries over the next 12-18 months.
- Forming partnerships with Max Healthcare, AIIMS Jammu, and Shankara Hospital for in-hospital labs.
- Aiming to decentralize testing access across India through hospital integrations.
Earlier rounds
- 2024 · Series A · Rs 50 Cr · led by Yali Capital
- Jan 2026 · Series B Tranche 1 · Rs 90 Cr · led by Ashish Kacholia, Lashit Sanghvi
Words to know
- Precision Oncology
- Tailoring cancer treatment based on individual genetic makeup and disease characteristics.
- Genomics
- The study of an organism's complete set of DNA including all genes.
- Multimodal Datasets
- Combining different types of data such as images, text, and genetic sequences for analysis.
- Clinical Decision Support
- Systems that help healthcare providers make better medical decisions using data and AI.
The numbers around it
4baseCare has 2 funding rounds in StopDown's archive, Rs 128 Cr raised in all.
| When | Round | Amount | Led by |
|---|---|---|---|
| 27 January 2026 | series-b | ₹90 crore | Ashish Kacholia |
Healthcare & Life Sciences in June 2026: 11 rounds with a disclosed amount, $118 million in all; the biggest was Vetic ($40 Mn). Every sector this year →
Other articles talking about it
The Economic Times ↗entrepreneur.economictimes.indiatimes ↗Inc42 ↗Your Story ↗Entrackr ↗Entrackr ↗Indian Startup News ↗
Terms in this story
- Funding stage: Startups raise money in steps called funding stages: pre-seed, seed, Series A, B, C and later, ending in a listing or a sale. Each step is larger and asks for more proof. In India, Series A rounds run from a few million dollars to about $15 million, as of November 2026.
- Series B/C: Series B, C, D and later rounds are growth rounds: large cheques for a startup with a proven model that wants to expand, enter new markets or move toward profit and a listing. In India they are usually priced in CCPS and, when foreign investors take part, must follow FEMA pricing rules.
Read next
FundingAugust AI raises $12M for US expansionAugust AI offers an AI health assistant that answers medical questions through WhatsApp and a mobile appFundingVitusCare raises $3 million Series BVitusCare runs dialysis units inside partner hospitals, which keeps costs low, and has grown from 22 to over 60 centresLaunchKapiva gives away Dia Free Juice on World Diabetes DayKapiva is a Bengaluru-based Ayurveda wellness brand selling herbal juices and supplements, with a flagship juice aimed at people managing blood sugar
Everything on 4baseCare → · All startup news on 11 June 2026 →
Is this 4baseCare? Get your “Featured on StopDown” badge →